137 related articles for article (PubMed ID: 26256278)
1. Molecular analysis of interactions between a PAMAM dendrimer-paclitaxel conjugate and a biomembrane.
He X; Lin M; Lu T; Qu Z; Xu F
Phys Chem Chem Phys; 2015 Nov; 17(44):29507-17. PubMed ID: 26256278
[TBL] [Abstract][Full Text] [Related]
2. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
3. Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Bhatt H; Ghosh B; Biswas S
Int J Pharm; 2019 Feb; 557():329-341. PubMed ID: 30599231
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of interactions between dendrimers and asymmetric membranes at different transport stages.
He X; Qu Z; Xu F; Lin M; Wang J; Shi X; Lu T
Soft Matter; 2014 Jan; 10(1):139-48. PubMed ID: 24651532
[TBL] [Abstract][Full Text] [Related]
5. Aqueous poly(amidoamine) dendrimer G3 and G4 generations with several interior cores at pHs 5 and 7: a molecular dynamics simulation study.
Kavyani S; Amjad-Iranagh S; Modarress H
J Phys Chem B; 2014 Mar; 118(12):3257-66. PubMed ID: 24588382
[TBL] [Abstract][Full Text] [Related]
6. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
Jain V; Maiti PK; Bharatam PV
J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
[TBL] [Abstract][Full Text] [Related]
7. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Ghosh B; Biswas S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):847-859. PubMed ID: 29790795
[TBL] [Abstract][Full Text] [Related]
8. On the ability of PAMAM dendrimers and dendrimer/DNA aggregates to penetrate POPC model biomembranes.
Ainalem ML; Campbell RA; Khalid S; Gillams RJ; Rennie AR; Nylander T
J Phys Chem B; 2010 Jun; 114(21):7229-44. PubMed ID: 20455596
[TBL] [Abstract][Full Text] [Related]
9. Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis.
Yamashita S; Katsumi H; Shimizu E; Nakao Y; Yoshioka A; Fukui M; Kimura H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2020 Dec; 157():85-96. PubMed ID: 33039547
[TBL] [Abstract][Full Text] [Related]
10. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.
Marcinkowska M; Stanczyk M; Janaszewska A; Sobierajska E; Chworos A; Klajnert-Maculewicz B
Pharm Res; 2019 Sep; 36(11):154. PubMed ID: 31482205
[TBL] [Abstract][Full Text] [Related]
11. Solubility enhancement of paclitaxel using a linear-dendritic block copolymer.
Zhou Z; D'Emanuele A; Attwood D
Int J Pharm; 2013 Aug; 452(1-2):173-9. PubMed ID: 23651641
[TBL] [Abstract][Full Text] [Related]
12. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
Khandare JJ; Jayant S; Singh A; Chandna P; Wang Y; Vorsa N; Minko T
Bioconjug Chem; 2006; 17(6):1464-72. PubMed ID: 17105225
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
15. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.
Teow HM; Zhou Z; Najlah M; Yusof SR; Abbott NJ; D'Emanuele A
Int J Pharm; 2013 Jan; 441(1-2):701-11. PubMed ID: 23089576
[TBL] [Abstract][Full Text] [Related]
16. PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance.
Anbazhagan R; Muthusamy G; Krishnamoorthi R; Kumaresan S; Rajendra Prasad N; Lai JY; Yang JM; Tsai HC
Biotechnol Bioeng; 2021 Mar; 118(3):1213-1223. PubMed ID: 33289076
[TBL] [Abstract][Full Text] [Related]
17. Aggregation properties of a polymeric anticancer therapeutic: a coarse-grained modeling study.
Peng LX; Yu L; Howell SB; Gough DA
J Chem Inf Model; 2011 Dec; 51(12):3030-5. PubMed ID: 21995420
[TBL] [Abstract][Full Text] [Related]
18. One platform comparison of solubilization potential of dendrimer with some solubilizing agents.
Jain S; Kesharwani P; Tekade RK; Jain NK
Drug Dev Ind Pharm; 2015 May; 41(5):722-7. PubMed ID: 24641446
[TBL] [Abstract][Full Text] [Related]
19. Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer.
Bellini RG; Guimarães AP; Pacheco MA; Dias DM; Furtado VR; de Alencastro RB; Horta BA
J Mol Graph Model; 2015 Jul; 60():34-42. PubMed ID: 26093506
[TBL] [Abstract][Full Text] [Related]
20. PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern.
Maingi V; Kumar MV; Maiti PK
J Phys Chem B; 2012 Apr; 116(14):4370-6. PubMed ID: 22420638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
